文献速递腹部技术与安全US

高危肝细胞癌患者中采用全氟丁烷的改良CEUS LI-RADS:系统评价与网状Meta分析

Modified CEUS LI-RADS With Perfluorobutane in Patients at High-Risk for Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · Ultrasound Med Biol · 2025-07-10

该系统评价与网状Meta分析整合9项研究及三个医疗中心原始数据,共1505例患者1622个病灶,比较未改良与改良CEUS LI-RADS采用全氟丁烷诊断肝细胞癌的性能。改良版汇总敏感度高于未改良版(0.77 vs 0.70),特异度相近(0.86 vs 0.86),诊断比值比(16.98 vs 12.51,p=0.02)与优越指数(1.59 vs 0.80,p=0.02)均更高,提示改良CEUS LI-RADS可能具有更优诊断性能,在不降低特异度的情况下提高敏感度。

要点

  • 改良CEUS LI-RADS采用全氟丁烷的汇总敏感度0.77,高于未改良版的0.70。
  • 两版汇总特异度均为0.86,改良版未降低特异度。
  • 改良版诊断比值比16.98、优越指数1.59,均高于未改良版且差异有统计学意义(p=0.02)。

核心结论

  • 改良CEUS LI-RADS采用全氟丁烷可能具有更优诊断性能,在不降低特异度的情况下提高敏感度。

研究设计与样本

  • 系统评价与网状Meta分析,整合9项研究及三个医疗中心原始数据,共1505例患者1622个病灶,采用ANOVA臂基模型比较未改良与改良CEUS LI-RADS的诊断比值比和优越指数。

临床应用与阅片要点

  • 作者认为改良CEUS LI-RADS采用全氟丁烷可能具有更优诊断性能,在不降低特异度的情况下提高敏感度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Contrast-enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) 2017 version is based on pure-blood pool contrast agent, potentially unsuitable for perfluorobutane contrast agent with the Kupffer phase. This article aimed to compare the diagnostic performance of unmodified CEUS LI-RADS and modified CEUS LI-RADS using perfluorobutane for hepatocellular carcinoma by integrating published and original data from three medical centers. Comparison between unmodified and modified CEUS LI-RADS with perfluorobutane involved ranking the diagnostic odds ratio (DOR) and superiority index (SI) using an ANOVA arm-based model. This meta-analysis included nine studies and our original data, encompassing 1505 patients with 1622 lesions. The summarized sensitivity of the modified CEUS LI-RADS was higher than that of the unmodified version (0.77 [0.72-0.81] vs. 0.70 [0.63-0.76]), while specificity was similar for both (0.86 [0.78-0.91] vs. 0.86 [0.77-0.92]). The general diagnostic performance of the modified CEUS LI-RADS was superior to the unmodified version, indicated by a higher DOR (16.98 [11.65-23.43] vs. 12.51 [8.11-18.44], p = 0.02) and SI (1.59 [1.00-3.00] vs. 0.80 [0.33-1.00], p = 0.02). Modified CEUS LI-RADS may be of better diagnostic performance, offering higher sensitivity without compromising specificity.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Chen J, Zhu J, Shen J, et al. Modified CEUS LI-RADS With Perfluorobutane in Patients at High-Risk for Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis. Ultrasound Med Biol. 2025. PMID: 40645805. doi:10.1016/j.ultrasmedbio.2025.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。